SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-Oct-24 8:30 AM View: | Aprea Therapeutics, Inc. (APRE) | 11-Oct-24 | Private Purchase | 50 | $2.46 | $123.19 | < 1% 19.32K to 19.37K | |
15-Oct-24 8:30 AM View: | Aprea Therapeutics, Inc. (APRE) | 10-Oct-24 | Market Purchase | 450 | $2.61 | $1,174.50 | 2% 18.87K to 19.32K | 7% |
28-Mar-24 5:59 PM View: | Aprea Therapeutics, Inc. (APRE) | 28-Mar-24 | Grant | 3,365 | -- | -- | 22% 15.5K to 18.87K | |
14-Mar-24 8:54 PM View: | Aprea Therapeutics, Inc. (APRE) | 13-Mar-24 | Purchase | 1,010 | $7.29 | $7,362.90 | 7% 14.49K to 15.5K | |
27-Feb-23 6:37 PM View: | Aprea Therapeutics, Inc. (APRE) | 27-Feb-23 | Grant | 1,000 | $5.25 | $5,250.00 | 7% 13.49K to 14.49K | |
30-Jan-23 5:21 PM View: | Aprea Therapeutics, Inc. (APRE) | 30-Jan-23 | Grant | 269,879 | -- | -- | 100% 0 to 269.88K | |
26-Jul-22 4:38 PM View: | Discovery Laboratories Inc. (WINT) | 26-Jul-22 | Private Purchase | 3,000 | $0.37 | $1,099.80 | 4% 69.8K to 72.8K | |
07-Mar-22 5:52 PM View: | Discovery Laboratories Inc. (WINT) | 04-Mar-22 | Grant | 66,300 | -- | -- | 1894% 3.5K to 69.8K | |
19-Apr-21 7:49 AM View: | Discovery Laboratories Inc. (WINT) | 16-Apr-21 | Purchase | 1,000 | $2.07 | $2,066.90 | 40% 2.5K to 3.5K | |
25-Mar-21 4:44 PM View: | Discovery Laboratories Inc. (WINT) | 25-Mar-21 | Purchase | 1,500 | $3.25 | $4,875.00 | 150% 1.0K to 2.5K | |
09-Oct-20 8:06 AM View: | Discovery Laboratories Inc. (WINT) | 07-Oct-20 | Purchase | 1,000 | $5.27 | $5,270.00 | 100% 0 to 1.0K | |
04-Jun-19 4:52 PM View: | Trevena, Inc. (TRVN) | 03-Jun-19 | Payment of Exercise | 5,516 | $1.17 | $6,453.72 | (6%) 87.75K to 82.23K | 36% |
04-Jun-19 4:52 PM View: | Trevena, Inc. (TRVN) | 31-May-19 | Market Purchase | 7,500 | $1.16 | $8,700.00 | 9% 80.25K to 87.75K | (35%) |
10-Dec-18 4:49 PM View: | Trevena, Inc. (TRVN) | 06-Dec-18 | Grant | 80,000 | -- | -- | 32000% 0.25K to 80.25K |